The Real Dangers of Grey-Market GLP-1s and Peptides

If you have seen semaglutide or tirzepatide offered online for a fraction of what a licensed pharmacy charges, you are not alone, and it makes sense that the price caught your eye. These medications are expensive, and money is real. But on this topic the message is plain: stay away from the grey market.

Overseas sellers, no-prescription websites, and “research” peptide vendors will ship GLP-1s and other peptides to almost anyone. The problem is that nobody can tell you what is actually in what they send. This page covers what regulators and researchers have documented, why an injection raises the stakes, how to check a pharmacy before you buy, and what to do if you are already using a grey-market product.

What counts as the grey market for GLP-1s

The grey market (sometimes called the black market) is any source operating outside the licensed, regulated system. That includes sellers shipping active ingredient from overseas, websites that sell a prescription drug with no prescription and no provider, and the large market of peptides labeled “research use only” or “not for human consumption.” That label is a legal dodge, not a safety promise. The FDA has warned companies selling semaglutide and tirzepatide labeled this way, noting the products were sold to consumers for human use with dosing instructions.^[4]

None of these sellers is a US-licensed pharmacy. No state board inspects them, and nobody checks what goes into the vial.

This is not hypothetical. It is documented.

You do not have to take anyone’s word for the danger. The public record already shows it.

Counterfeit pens in the US supply chain

In December 2023, the FDA warned consumers not to use counterfeit semaglutide pens found in the US drug supply chain, and said it had seized thousands of units. Analysis found the needles in the seized product were counterfeit, so their sterility could not be confirmed, which raises the risk of infection.^[1] The FDA updated that warning in April 2025 and December 2025 as more counterfeit lots turned up. In at least one case the fakes carried a lot number that was also used on authentic pens, so a lot number alone does not tell you whether a pen is real.^[1]

In June 2024, the World Health Organization issued a medical product alert on three falsified batches of semaglutide pens detected in Brazil, the UK, and the US. WHO warned that falsified products may lack the active ingredient or contain a different, undeclared ingredient such as insulin, which creates unpredictable health risks.^[2]

Dosing errors

In July 2024, the FDA alerted providers, compounders, and patients to adverse events, some requiring hospitalization, from dosing errors with compounded injectable semaglutide in multiple-dose vials. Some people took 5 to 20 times the intended dose. Much of the confusion came from mixing up milliliters, milligrams, and “units”: someone told to draw 5 units drew 50 instead.^[3] A grey-market vial often comes with no dosing instructions at all.

Adverse event reports

As of May 31, 2026, the FDA had received 990 adverse event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide.^[4] A report does not by itself prove the product caused the event, and these reports cover compounded products generally, including those from licensed pharmacies. What matters is the gap: licensed pharmacies sit inside a system where problems can be reported and traced. Grey-market sellers report nothing to anyone.

What researchers found when they bought it online

If you are thinking about buying semaglutide or other peptides from a website that does not ask for a prescription, it helps to know what researchers found when they bought semaglutide that way.

A 2024 study in the Journal of Medical Internet Research identified 59 illegal online pharmacy websites selling semaglutide without a prescription, then test-purchased from six of them.^[5] Here is what happened:

• Three orders for pens never arrived. Those sellers took the money and shipped nothing.
• Three orders for vials did arrive, and all of them were judged probably substandard or falsified.
• Bacterial endotoxin was detected in every sample. Endotoxins are fragments of bacteria that can cause fever and inflammatory reactions when injected.
• Labels claimed 99% purity. Measured semaglutide purity ranged from 7.7% to 14.37%.
• The amount of semaglutide in each vial was 28.56% to 38.69% higher than the label said.

A companion study by the same research group in JAMA Network Open looked at the safety risks of these no-prescription purchases.^[6]

That endotoxin finding is the trap with “purity certificates.” A certificate, if it is real, describes the molecule. It does not tell you what else is in the vial, whether the vial is sterile, or whether the dose on the label matches the dose inside. And products sold as “research peptides,” including investigational molecules such as retatrutide, are unapproved drugs, and the FDA has warned companies selling them.^[4]

Why an injection raises the stakes

This is what makes a grey-market GLP-1 different from a bad purchase of almost anything else: you inject it. It goes under your skin, on your own, often with no provider who knows your history, no clear dosing instructions, and no one to call when something feels wrong.

A counterfeit handbag costs you money. A non-sterile, mislabeled injection can put you in the hospital. The test purchases above found more drug than the label stated, very low purity, and bacterial endotoxin in every vial, and regulators warn that fakes may contain a different drug entirely. With an injection, there is no step between the vial and your bloodstream where any of that gets caught. “Probably fine” is not a good enough standard here.

Is cheap semaglutide safe? Why cheaper is a mirage

The money is the whole reason the grey market exists. Yes, the price is lower. It is lower because every safeguard that costs money has been removed: the licensing, the testing, the sterile preparation, the prescription, the provider, and the recourse when something goes wrong.

You are not getting the same thing for less. You are getting a different and riskier product, and paying for it with your health instead of dollars. In the 2024 test purchases, half the sellers delivered nothing at all.^[5] The FDA lists “deep discounts or prices that seem too good to be true” as a warning sign.^[4] If a price sits far below what licensed pharmacies charge, treat that as the red flag.

How to check a pharmacy before you buy

You do not need inside knowledge to check a source. These are public checks anyone can run in a few minutes, and the FDA’s BeSafeRx page walks through the same basics.^[7]

What a legitimate source looks like

• It requires a prescription from a licensed provider. A licensed provider (a physician, nurse practitioner, or physician assistant) reviews your health history and decides whether a prescription is appropriate. A site that skips this step is not a pharmacy you should use.
• Its license checks out. Look the pharmacy up on its state board of pharmacy website. If it ships to you from another state, also check whether it holds a license for the state you live in.
• It passes independent verification. Enter the website address in the Safe Site Search tool on Safe.Pharmacy, run by the National Association of Boards of Pharmacy (NABP).^[8] LegitScript’s public certification lookup is another check you can run.
• It is reachable. Confirm a US street address and a licensed pharmacist you can actually contact with questions.
• It tells you what kind of pharmacy makes compounded products. Ask whether a compounded product comes from a 503A pharmacy (which compounds for individual prescriptions under state board oversight) or a 503B outsourcing facility (which registers with the FDA). Registered 503B facilities appear on the FDA’s outsourcing facilities list.^[9]

Red flags that mean walk away

• No prescription required, or a “prescription” from a quick checkbox form
• Labels that say “research use only” or “not for human consumption”
• Prices far below what licensed pharmacies charge
• Payment only by cryptocurrency, wire transfer, or gift card
• No license number and no US street address
• Vials of powder you are told to mix yourself, with no instructions

None of these checks makes a compounded product FDA-approved. They tell you whether a licensed, accountable pharmacy stands behind what you receive.

If you are already using a grey-market product

If this describes you, you have not done anything shameful. High prices push people toward these sellers, and the marketing is designed to look legitimate. What matters now is getting you onto safer footing.

1. Stop using it, and keep everything. Hold on to the vial, packaging, labels, and receipts. They help a provider, a poison center, or the FDA understand what you were exposed to.
2. Tell a licensed provider the truth. Say what you took, how much, and where it came from. A provider can only help with what they know.
3. Know the symptoms that need care now. Seek urgent care for severe or persistent vomiting, severe abdominal pain (especially pain that reaches your back), signs of dehydration such as dizziness or very little urine, fainting, redness, swelling, or pus at the injection site, or signs of an allergic reaction such as swelling of the face or trouble breathing. Call 911 for a medical emergency.
4. Call Poison Help if you are unsure. The Poison Help line, 1-800-222-1222, connects you to your local poison center through America’s Poison Centers. It is free, confidential, and open 24 hours a day, 7 days a week.^[10]
5. Report it. You can report side effects or a suspect product to FDA MedWatch at fda.gov/medwatch.^[11] You can report a suspicious online seller to the FDA through its BeSafeRx page.^[7]

The bottom line

The savings from a grey-market GLP-1 are real. So are the counterfeit pens, the contaminated vials, the dosing errors, and the sellers who take payment and ship nothing. The trade is not a fair one. Whatever you decide, get your medication through a licensed provider and a licensed pharmacy you have checked yourself.

What to read next

For the detailed breakdown of how the grey market operates and what a licensed pharmacy does differently, read The Grey Market: Why Overseas GLP-1s and Peptides Are a Gamble and Inside a 503A Pharmacy. For a fuller pharmacy checklist, see How to Choose a Safe Compounding Pharmacy for GLP-1 Medication. You can also follow current GLP-1 Recalls and FDA Safety Alerts.

Sources

1. U.S. Food and Drug Administration. “FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain.” First issued December 21, 2023; updated April 14, 2025 and December 5, 2025. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-warns-consumers-not-use-counterfeit-ozempic-semaglutide-found-us-drug-supply-chain
2. World Health Organization. “WHO issues warning on falsified medicines used for diabetes treatment and weight loss” (Medical Product Alert N2/2024). June 20, 2024. https://www.who.int/news/item/20-06-2024-who-issues-warning-on-falsified-medicines-used-for-diabetes-treatment-and-weight-loss
3. U.S. Food and Drug Administration. “FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products.” July 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
4. U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of October 1, 2026; adverse event counts as of May 31, 2026. Accessed October 17, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
5. Ashraf AR, Mackey TK, Vida RG, et al. “Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.” J Med Internet Res. 2024;26:e65440. doi:10.2196/65440. PMID 39509151. https://pubmed.ncbi.nlm.nih.gov/39509151/
6. Ashraf AR, et al. “Safety and Risk Assessment of No-Prescription Online Semaglutide Purchases.” JAMA Netw Open. 2024;7(8):e2428280. PMID 39093567. https://pubmed.ncbi.nlm.nih.gov/39093567/
7. U.S. Food and Drug Administration. “BeSafeRx: Your Source for Online Pharmacy Information” and “Considering an Online Pharmacy?” (content current as of September 21, 2020). Accessed October 17, 2026. https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/besaferx-your-source-online-pharmacy-information
8. National Association of Boards of Pharmacy. Safe.Pharmacy (Safe Site Search tool). Accessed October 17, 2026. https://safe.pharmacy/
9. U.S. Food and Drug Administration. “Registered Outsourcing Facilities.” Accessed October 17, 2026. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
10. America’s Poison Centers. Poison Help line, 1-800-222-1222. Accessed October 17, 2026. https://poisoncenters.org/
11. U.S. Food and Drug Administration. “MedWatch: The FDA Safety Information and Adverse Event Reporting Program.” Accessed October 17, 2026. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program